(D(CH2)51,TYR(ME)2,ORN8)-OXYTOCIN结构式
|
常用名 | (D(CH2)51,TYR(ME)2,ORN8)-OXYTOCIN | 英文名 | (d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin trifluoroacetate salt |
|---|---|---|---|---|
| CAS号 | 77327-45-8 | 分子量 | 1075.304 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 1537.6±65.0 °C at 760 mmHg | |
| 分子式 | C48H74N12O12S2 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | 883.7±34.3 °C |
(D(CH2)51,TYR(ME)2,ORN8)-OXYTOCIN用途
本网站展示的所有产品仅用作科学研究，不可食用，不可用于人体或动物的临床诊断和治疗。
(d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin (OVT) 是一种催产素受体拮抗剂。(d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin 可用于神经系统疾病的研究。 |
| 中文名 | (D(CH2)51,TYR(ME)2,ORN8)-OXYTOCIN |
|---|---|
| 英文名 | [Pmp1,Tyr(OMe)2,Orn8] Vasotocin |
| 英文别名 | 更多 |
| 描述 | (d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin (OVT) 是一种催产素受体拮抗剂。(d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin 可用于神经系统疾病的研究。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 1537.6±65.0 °C at 760 mmHg |
| 分子式 | C48H74N12O12S2 |
| 分子量 | 1075.304 |
| 闪点 | 883.7±34.3 °C |
| 精确质量 | 1074.499023 |
| PSA | 439.13000 |
| LogP | -2.55 |
| 蒸汽压 | 0.0±0.3 mmHg at 25°C |
| 折射率 | 1.625 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 安全声明 (欧洲) | 22-24/25 |
| 危险品运输编码 | NONH for all modes of transport |
|
Oxytocin enhances, and oxytocin antagonism decreases, sexual receptivity in intact female rats.
Neuropeptides 27(4) , 245-50, (1994) In intact, non-ovariectomized female rats in spontaneous behavioral estrus, the i.c.v. injection of oxytocin significantly increased lordosis quotient and lordosis duration, starting from a dose of 1 ... |
|
|
Effect of oxytocin receptor antagonists on the renal actions of oxytocin and vasopressin in the rat.
J. Endocrinol. 152(2) , 257-64, (1997) The effect of three oxytocin receptor antagonists on the renal actions of oxytocin and vasopressin was investigated in conscious male rats infused with hypotonic saline. Infusion of oxytocin at 100 pg... |
|
|
The oxytocin antagonist d(CH2)5Tyr(Me)2-Orn8-vasotocin reduces non-contact penile erections in male rats.
Neurosci. Lett. 265(3) , 171-4, (1999) Male rats show four to six penile erection episodes when put for 80 min in the presence of an inaccessible receptive female. These non-contact penile erections were reduced dose-dependently by d(CH2)5... |
| b-Mercapto-b,b-cyclopentaMethylene-propionyl-Tyr(Me)-Ile-Gln-Asn-Cys-Pro-Orn-Gly-NH2 |
| [D(CH2)51,TYR(ME)2,ORN8]-VASOTOCIN |
| (D(CH2)(5/1),TYR(ME)2,ORN8)-OXYTOCIN |
| PMP-TYR(ME)-ILE-GLN-ASN-CYS-PRO-ORN-GLY-NH2 |
| 1-{[(10R,13S,16S,19S,22S)-13-(2-Amino-2-oxoethyl)-16-(3-amino-3-oxopropyl)-19-[(2S)-2-butanyl]-22-(4-methoxybenzyl)-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentaazaspiro[5.19]pentacos-10-yl]carbonyl}-L-prolyl-L-ornithylglycinamide |
| Glycinamide, 1-[[(10R,13S,16S,19S,22S)-13-(2-amino-2-oxoethyl)-16-(3-amino-3-oxopropyl)-22-[(4-methoxyphenyl)methyl]-19-[(1S)-1-methylpropyl]-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentaazaspiro[5.19]pentacos-10-yl]carbonyl]-L-prolyl-L-ornithyl- |
| (D(CH2)51,(METHYL)TYR2,ORN8)-OXYTOCIN |
| me)(2)-orn(8) |
查看所有供应商和价格请点击：